Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesCannabinoids in health and diseaseThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinThe endocannabinoid system as an emerging target of pharmacotherapyPharmacotherapy of methamphetamine addiction: an updateAnalogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinityHarm reduction--the cannabis paradoxCellular Mechanisms of Action of Drug Abuse on Olfactory NeuronsThe selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in ratsIs smoking a causative factor of hypertension?The role of CB1 receptors in psychostimulant addictionInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionIdentification of a high-affinity binding site involved in the transport of endocannabinoids.New developments in the pharmacotherapy of cocaine abuseHigh reinforcing efficacy of nicotine in non-human primatesNicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the FutureAnimal models of cannabinoid reward.Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.Effects of the novel cannabinoid CB1 receptor antagonist PF 514273 on the acquisition and expression of ethanol conditioned place preference.Drug addiction.The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.Treatment of tobacco dependence: integrating recent progress into practice.N-(4-cyanotetrahydro-2H-pyran-4-yl) and N-(1-cyanocyclohexyl) derivatives of 1,5-diarylpyrazole-3-carboxamides showing high affinity for 18 kDa translocator protein and/or cannabinoid receptorsContrasting Effects of Lithium Chloride and CB1 Receptor Blockade on Enduring Changes in the Valuation of Reward.Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptorsRole of the endogenous cannabinoid system in nicotine addiction: novel insights.The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intakeAddiction and brain reward and antireward pathways.Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in miceDifferential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Three-Dimensional Biologically Relevant Spectrum (BRS-3D): Shape Similarity Profile Based on PDB Ligands as Molecular Descriptors.Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.Laboratory models of alcoholism: treatment target identification and insight into mechanisms.The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventions.Dopamine D3 receptor ligands for the treatment of tobacco dependence.
P2860
Q24623282-2EAF5C3A-4647-45CD-AEA3-E0AFB9D54ACCQ24633884-3BE6BFAE-83E3-494C-B754-DBA09A78C506Q24643876-CB0202CD-C521-44E8-B346-939838EB43A6Q24648473-8D14C2E1-4EAD-432F-9274-C7853F2687AEQ24648913-64CA450E-FAEA-46B4-8492-E9CBB66F684DQ24650317-CF5C9AB5-B9F2-467A-81EB-BB3AD430505CQ24814542-CB707418-9113-4AD4-B7F9-13E6E29610ABQ26772009-EEF7A246-8452-4809-BE40-D97DF85F494CQ28256384-96DDDC95-54B0-4EDF-9818-69680D1FFC9FQ28263108-2118608C-C8A9-46AF-BBCB-57CAFB12DDCAQ28280265-5E110D15-AC00-426F-B041-148AC7AF222BQ28283718-81A90337-6948-4F0B-B49C-AD823964FCA3Q28284073-BFDE0D5C-F0CA-4661-B9D7-5A2E7CA8FC9FQ28302782-A55CFE1A-D2F6-4B50-B205-2329D4064A60Q28469129-06069F89-9A0C-41FD-862B-98BAE21DDDB6Q30244252-7803208F-A103-4974-BBAF-EC6D6D3D060FQ30366778-7FCABC04-43C1-4566-93DA-FE75BCCF26EDQ30499463-C756E623-012D-4B98-AEDE-528AF1838A0BQ33759649-54E7F9D4-CB71-4CC1-87B6-646B75CD61CBQ33980198-D2548612-D6D7-416D-9A74-5FC705ED972AQ34098204-B1446735-B33C-40A1-AE2F-903CD0AC675EQ34280424-9B6FA1ED-A36B-4BB0-851F-6D12CDAD5F76Q34301263-F9518070-EB2F-48B5-B25F-FD419A8A59F0Q34575484-50D173FB-E066-48FA-969F-65CC77969640Q34613459-6FED2BCE-01D9-4E84-86BD-3985EDFEC04FQ34660703-E6E6E7CD-312D-4F4B-B19E-70BB6DE2B732Q34715360-14B982AF-B8D8-468D-B116-E89CCFA3A412Q34904406-36FF634F-2963-4514-A8BF-25BDA5C40F72Q35196842-A1FEB0DA-F5C0-4392-8F4D-31D2ADA9FCEAQ35202878-0BDFA518-9FE5-418D-B78D-24E77541FB30Q35216481-746A7718-4610-4217-B37C-03D72405D667Q35593066-95463ECC-2D56-44C1-8E6E-A520FCC908B4Q35995170-0CE96A14-7B1B-4C87-A189-8655C2D94A69Q36057601-F8BF4A76-99AC-4C5D-892F-F50F9187A3B1Q36176444-F2C65F00-F07F-418B-9A90-14FCF1D6CE63Q36199304-6CF9DF5A-87FE-4FA1-B291-3137721C4F26Q36201313-315FBC5B-CE3A-4ADC-B07D-626516D23A39Q36298365-C4955ADC-FC8A-4659-A56B-B850ED849D3CQ36540309-E57535D9-A477-4206-B041-20BD9309780AQ36677397-4BAD5459-D42D-4CC0-932E-C81B7241A515
P2860
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@ast
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@en
type
label
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@ast
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@en
prefLabel
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@ast
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
@en
P921
P356
P1476
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
@en
P2093
Steven R Goldberg
P304
P356
10.1124/JPET.104.077974
P407
P577
2004-11-03T00:00:00Z